Impact Factor
3.71
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.01
667 total citations
h5-index
33
h5 depth signal
Cited share
80.3%
139 of 173
Total citations
667
Citation footprint
Metric signal
4.90
External metric anchor
Self-citation
0.9%
6 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
406
China
256
United States
195
Italy
146
Brazil
79
Citing Fields of Research
Immunology
152
Oncology
126
Drug Delivery Systems
125
Phytochemicals
115
Neurodegenerative Disorders
102
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,504
Articles tracked across the journal lifetime
Indexed publication set
173
139 cited publications
Last 12 months
129
11.7 publications/month
Open access share
0.8%
1 OA publications in the last year
Leading citing country
India
406 citing publications
Leading citing field
Immunology
152 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, July 2000-
v1n1, July 2000-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurodegenerative Disorders
Phytochemicals
Immunology
Drug Delivery Systems
Protein Structure & Folding
Noncoding RNA
Diabetes
Broad Categories
Drug Therapy
Phytochemicals
Immunology
Drug Delivery Systems
Parasitology Studies
Cancer, Autophagy & Apoptosis
Polymer & Macromolecule Science
Noncoding RNA
MeSH Descriptors
Drug Delivery Systems
Drug Design
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/0113894501509463261008055141
Open DOI
Discovery and Mechanistic Investigation of a Novel Kinase Inhibitor Targeting EGFR Resistance Mutations
Background: The Epidermal Growth Factor Receptor (EGFR) serves as a core target in tumor-targeted therapy. Mutations in EGFR frequently lead to resistance against clinical Tyrosine Kinase Inhibitors (TKIs), underscoring the critical need...
02
DOI 10.2174/0113894501502300261013021007
Open DOI
Decoding the Molecular Target Landscape of Chalcones: An Integrated Cheminformatics Analysis Using PubChem Patent Data, Protein Target Profiling, and Bioassay Activity Mapping
Background: Chalcones are α,β-unsaturated ketone scaffolds with broad documented bioactivity. No prior study has simultaneously integrated structural validation, PAINS assessment, chemical-space clustering, human-target classification, b...
03
DOI 10.2174/0113894501515184261009095214
Open DOI
Topical Emulgel of Epigallocatechin Gallate and Olive Oil: A Quality-by-design Approach for Managing Chemotherapy-induced Alopecia
Introduction: Chemotherapy-Induced Alopecia (CIA) is a stressful effect associated with cancer therapy, mainly affecting hair follicles. Epigallocatechin Gallate (EGCG), a bioactive polyphenol, can be used for its antioxidant and hair gr...
04
DOI 10.2174/0113894501525537261009064503
Open DOI
Computational Evaluation of Hydnocarpin as a Novel ROCK2 Inhibitor and Potential Regulator of Mitophagy in Cancer
Introduction: Impaired mitophagy in cancer cells leads to the accumulation of dysfunctional mitochondria, elevated ROS, and activation of pro-survival pathways, promoting tumour growth and metabolic adaptation. ROCK2, a serine/threonine ...
05
DOI 10.2174/0113894501512320261007111548
Open DOI
HNF4-α Knockout Promotes HepG2 Cell Migration and Reduces Mitochondrial Membrane Potential under Hypoxic Conditions
Introduction/Objective: Hypoxia is a critical component of the tumor microenvironment contributing to metabolic reprogramming and drug resistance. Subsequently, elucidating the molecular mechanisms involved in hypoxia regulation in tumor...
06
DOI 10.2174/0113894501494052261006091856
Open DOI
Computational Drug Repurposing Reveals Lopinavir and Ritonavir as Potential Inhibitors of APOL Proteins for Combating Kidney and Neuropsychiatric Disorders
Introduction: The Apolipoprotein L (APOL) family, particularly APOL1, APOL2, and APOL4, has been implicated in the pathogenesis of kidney injury, neuroinflammation, and several psychiatric disorders. However, there are currently no appro...
07
08
DOI 10.2174/0113894501519368261006050518
Open DOI
TYK2–Wnt5a Crosstalk in Psoriatic Arthritis: A Hypothesized Immunopharmacological Axis for Inflammation and Structural Remodelling
Introduction: Psoriatic Arthritis (PsA) is a chronic immune-mediated inflammatory disease marked by synovitis, enthesitis, bone erosion, and pathological new bone formation, via the Interleukin-23/T helper cell-17 (IL-23/Th17) axis. Tyro...
09
DOI 10.2174/0113894501509464261006043242
Open DOI
Sulfamethoxazole Attenuates Aluminum-induced Cognitive Impairment: In silico Evidence for BACE1 Interaction and In vivo Behavioral Assessment
Introduction/Objective: BACE1 (Beta-Site Amyloid precursor protein-cleaving enzyme is a rate-limiting aspartic protease responsible for beginning Amyloid-β (Aβ) peptide synthesis, the major neurotoxic characteristic of Alzheimer's Diseas...
10
DOI 10.2174/0113894501520248261002101424
Open DOI
In silico Prediction of Protein Targets for Benzofuranone Ring-containing Agents and Molecular Docking Analysis
Background: Benzofuranone and its derivatives, which serve as drug precursors and intermediates due to their biological activity, are of great importance in the pharmaceutical industry. These heterocyclic molecules, composed of benzene a...
Bibliographical & Catalog Notes
Title from cover.
Vol. 1 complete in 4 issues.
Also issued online.
v. 1, no. 1 (July 2000)20020111 Notice not published Printed on acid-free paper